December 27th 2025, 3:00pm
Oya Gilbert, diagnosed with multiple myeloma in 2017, advises patients to bring someone to appointments, ask questions and seek second opinions.
December 27th 2025, 7:00pm
Cancer survivor and author Bill Potts was recently honored as a Blood Cancer Hero.
December 26th 2025, 4:00pm
Orserdu plus Verzenio or Afinitor was well tolerated and showed early signs of effectiveness in advanced ER-positive, HER2-negative breast cancer.
December 26th 2025, 2:00pm
CURE spoke with an expert about why a support system is crucial for patients with lung cancer.
December 25th 2025, 4:00pm
BOOG 13-08 shows skipping sentinel lymph node biopsy in patients 50+ with early-stage, hormone receptor–positive, HER2-negative breast cancer is safe.
December 25th 2025, 2:00pm
Learn how diet and exercise impact breast cancer risk, while getting authoritative guidelines on plate balance, fiber goals, and complex vs. simple carbs.
December 24th 2025, 10:00pm
CURE was on site at the 2025 ASH Annual Meeting, sharing expert conversations and patient-focused reporting that highlighted progress in blood cancer care.
December 24th 2025, 8:00pm
All I can say is thank you Healthwell Foundation for giving our brother life, and for giving our whole family unit life. Because of you, we can keep on keeping on.
December 24th 2025, 4:00pm
Ceralasertib plus Imfinzi failed to improve overall survival versus docetaxel in a phase 3 study of previously treated non-small cell lung cancer.
December 24th 2025, 9:00pm
As kidney cancer survival improves, more patients report cognitive changes affecting memory, fatigue, and overall mental clarity
Advice for Patients Newly Diagnosed With Multiple Myeloma
A Five-Time Cancer Survivor’s Advice for Patients
Orserdu Combo Shows Potential for ER+/HER2– Breast Cancer
Advice for Patients Newly Diagnosed With Lung Cancer